Home
Team
Technology
Investors
Stock Price
News
Financial Information
Analyst & Media Coverage
Presentations
R&D Papers
Clinical Papers & Abstracts
Conference Posters, Abstracts & Presentations
Corporate Governance
Pipeline
Contact Us
L-DOS47 Phase I Study Results to be Presented at the 9th International Conference of Contemporary Oncology
Home
L-DOS47 Phase I Study Results to be Presented at the 9th International Conference of Contemporary Oncology
21/03/2017
21/10/2023
admin
0 Comments
FY2017
Post navigation
Previous:
Helix Biopharma Corp. Announces Fiscal Second Quarter 2017 Results and Closing of Private Placement
2017 3rd CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (poster)
:Next